Oncolytics Biotech
ONCYOncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodif …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Oncolytics Biotech
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/12/2026 | Buy | Kelly, Jared | Chief Executive Officer | $1.0 | $4,848 |
| 3/11/2026 | Buy | Parsons, James T. | Director | $1.0 | $10,300 |
| 2/12/2026 | Buy | Andrews, Patricia S. | Director | $0.9 | $30,292 |
| 2/12/2026 | Buy | Brown, Deborah Margaret | Director | $0.8 | $21,240 |
| 2/12/2026 | Buy | Hagerman, Allison | VP, Product Development | $0.8 | $8,298 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)